Cytek Biosciences, Inc. (CTKB)
NASDAQ: CTKB · Real-Time Price · USD
5.84
+0.32 (5.80%)
At close: Nov 13, 2026, 4:00 PM EST
5.84
0.00 (0.00%)
After-hours: Nov 13, 2026, 4:15 PM EST
Cytek Biosciences Market Cap
Cytek Biosciences has a market cap or net worth of $763.78 million as of November 13, 2026. It is the 12,014th most valuable company in the world and the 2,441st biggest in the United States. Its market cap has increased by 24.19% in one year.
Market Cap
763.78M
Enterprise Value
532.57M
1-Year Change
24.19%
Global Rank
Country Rank
#2,441 United States
Category
ChartMarket Cap Chart
Since the IPO on July 23, 2021, Cytek Biosciences's market cap has decreased from $2.26B to $763.78M, a decrease of -66.22%. That is a compound annual growth rate of -18.48%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 13, 2026 | 763.78M | 18.28% |
| Dec 31, 2025 | 645.72M | -22.76% |
| Dec 31, 2024 | 835.98M | -32.38% |
| Dec 29, 2023 | 1.24B | -10.21% |
| Dec 30, 2022 | 1.38B | -36.91% |
| Dec 31, 2021 | 2.18B | -3.47% |
| Jul 23, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Beta Bionics | 968.28M |
| Bioventus | 926.03M |
| OrthoPediatrics | 879.14M |
| QuidelOrtho | 817.18M |
| InMode | 789.21M |
| Varex Imaging | 775.10M |
| Delcath Systems | 757.34M |
| Pacific Biosciences of California | 654.02M |